Vanguard Group Inc Applied Therapeutics Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,010,290 shares of APLT stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,010,290

Previous 3,230,481 6.82%

Holding current value

$14.1 Million

Previous $10.8 Million 89.14%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.25 - $7.4 $495,429 - $1.63 Million	-220,191 Reduced 6.82%	3,010,290 $20.5 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $3.32 Million - $6.04 Million	1,801,827 Added 126.12%	3,230,481 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.77 $543,881 - $1.2 Million	431,652 Added 43.29%	1,428,654 $3.56 Million
Q2 2023 Aug 14, 2023	BUY	$0.77 - $1.8 $109,222 - $255,324	141,847 Added 16.59%	997,002 $1.28 Million
Q1 2023 May 15, 2023	BUY	$0.75 - $1.21 $43,944 - $70,897	58,593 Added 7.36%	855,155 $692,000

Q4 2022 Feb 10, 2023	BUY	$0.65 - $1.12 $223,144 - $384,494	343,299 Added 75.74%	796,562 $605,000
Q3 2022 Nov 14, 2022	SELL	$0.86 - $1.55 $52,422 - $94,481	-60,956 Reduced 11.85%	453,263 $422,000
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $73,452 - $255,150	-96,648 Reduced 15.82%	514,219 $488,000
Q1 2022 May 13, 2022	SELL	$1.48 - $6.22 $355,601 - $1.49 Million	-240,271 Reduced 28.23%	610,867 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $7,358 - $15,345	839 Added 0.1%	851,138 $7.62 Million
Q3 2021 Nov 12, 2021	BUY	$13.54 - $22.06 $73,346 - $119,499	5,417 Added 0.64%	850,299 $14.1 Million
Q2 2021 Aug 13, 2021	BUY	$14.05 - $25.04 $11.9 Million - $21.2 Million	844,882 New	844,882 $17.6 Million

Others Institutions Holding APLT

# of Institutions

100

Shares Held

94M

Call Options Held

5.83M

Put Options Held

231K

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $224M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Applied Therapeutics Inc. Transaction History